Know Labs is changing how we can analyze and monitor molecules non-invasively. The revolutionary Bio-RFID™ platform uses radiofrequency spectroscopy and can be integrated into a variety of wearable, mobile, or bench-top form factors. The first application is a glucose monitoring device that will provide the user with real-time information on their blood glucose levels, assisting billions of people with diabetes and pre-diabetes to manage this medical condition. Know Labs is a public company whose shares trade under the stock symbol KNW (NYSE American).